No EUA For COVID-19 Vaccines Prior To Trials Completion, Says India

Russia To Conduct Phase III Trials In India

The Indian regulator says it is not considering emergency use authorization for COVID-19 vaccines before completion of clinical trials, a stand validated by AstraZeneca halting trials of its vaccine candidate due to an adverse event in UK. Meanwhile, India has signed up for Phase III trials of Russia’s vaccine candidate

Blue Planet Studio/Shutterstock.com
COVID-19 Vaccines Have Seen Regulator Stance Across The World Differ • Source: Shutterstock

In a pronouncement with implications for companies such as AstraZeneca PLC and Novavax, Inc., the Drugs Controller General of India (DCGI), V G Somani, has said the country’s regulatory body does not plan to permit emergency use authorizations (EUAs) for COVID-19 vaccines before the completion of clinical trials.

His comment at a virtual edition of the Annual BioPharma and Healthcare Summit of the USAIC (USA-India Chamber of Commerce)...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip